We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Regeneron Pharmaceuticals Inc | NASDAQ:REGN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.88 | -0.20% | 955.1163 | 953.85 | 954.90 | 962.10 | 950.27 | 958.00 | 91,015 | 16:49:38 |
1. Name and Address of Reporting Person * RYAN ARTHUR F | 2. Issuer Name and Ticker or Trading Symbol REGENERON PHARMACEUTICALS, INC. [ REGN ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 10/1/2020 | S(1) | 2 | D | $553.73 (2) | 28441 | D | |||
Common Stock | 10/1/2020 | S(1) | 8 | D | $554.61 (3) | 28433 | D | |||
Common Stock | 10/1/2020 | S(1) | 30 | D | $555.52 (4) | 28403 | D | |||
Common Stock | 10/1/2020 | S(1) | 10 | D | $556.5 (5) | 28393 | D | |||
Common Stock | 10/1/2020 | S(1) | 2 | D | $557.44 (6) | 28391 | D | |||
Common Stock | 10/1/2020 | S(1) | 11 | D | $558.63 (7) | 28380 | D | |||
Common Stock | 10/1/2020 | S(1) | 12 | D | $559.43 (8) | 28368 | D | |||
Common Stock | 10/1/2020 | S(1) | 6 | D | $560.41 (9) | 28362 | D | |||
Common Stock | 10/1/2020 | S(1) | 4 | D | $561.48 (10) | 28358 | D | |||
Common Stock | 10/1/2020 | S(1) | 5 | D | $562.63 (11) | 28353 | D | |||
Common Stock | 10/1/2020 | S(1) | 1 | D | $563.8 | 28352 | D | |||
Common Stock | 10/1/2020 | S(1) | 7 | D | $564.25 (12) | 28345 | D | |||
Common Stock | 10/1/2020 | S(1) | 2 | D | $565.22 (13) | 28343 | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
RYAN ARTHUR F 777 OLD SAW MILL RIVER ROAD TARRYTOWN, NY 10591 | X |
Signatures | ||
/s/**Arthur F. Ryan | 10/5/2020 | |
**Signature of Reporting Person | Date |
1 Year Regeneron Pharmaceuticals Chart |
1 Month Regeneron Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions